Formulations of polyinosinic acid and polycytidylic acid for the prevention of upper respiratory tract infections
CN109476675A
For treating the dihydropyran and pyrimidine derivatives of viral infection
MX2018008803A
Aryl substituted pyrimidines for use in influenza virus infection.
AU2017205261A1
Functionalized pentanoic acids for use in influenza viral infections
HK1226410A1
Crystal form of nucleoside inhibitor of hcv
CA3005514A1
Heterocyclic indoles for use in influenza virus infection
AU2016219555A1
Aqueous suspensions of TMC278
KR20180022833A
Antimicrobial compound
US2017002025A1
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
CN107820423A
For preventing and/or treating the poly I: C (poly- (I of the infection of the upper respiratory tract:C)) pea starch preparation
JO3637B1
Rsv antiviral pyrazolo- and triazolo-pyrimidine compounds
SG11201704397VA
Piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)
CA2963054A1
Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)
JP2016047839A
Treatment of amyloidogenic disease
MX2017002972A
Pyrrolopyrimidines for use in influenza virus infection.
CN106573920A
Indoles for use in influenza virus infection
WO2016020308A1
Compacted solid dosage form
IL239207D0
Antibacterial compounds
WO2015162192A1
Use of a hiv derived accessory protein for the reactivation of latent hiv
